Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16,401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease.
Fukada A, Fujisawa T, Hozumi H, Koda K, Akamatsu T, Oyama Y, Satake Y, Niwa M, Kaida Y, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Hashimoto D, Yoshida A, Gono T, Kuwana M, Yamano Y, Kondoh Y, Yamashita K, Maekawa M, Mori K, Inoue Y, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Inui N, Suda T. Fukada A, et al. Among authors: suzuki y. Arthritis Rheumatol. 2024 May;76(5):796-805. doi: 10.1002/art.42785. Epub 2024 Feb 6. Arthritis Rheumatol. 2024. PMID: 38146102
Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases.
Enomoto N, Naoi H, Mochizuka Y, Isayama T, Tanaka Y, Fukada A, Aono Y, Katsumata M, Yasui H, Mori K, Karayama M, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T. Enomoto N, et al. Among authors: suzuki y. BMC Pulm Med. 2022 Oct 26;22(1):387. doi: 10.1186/s12890-022-02197-3. BMC Pulm Med. 2022. PMID: 36289542 Free PMC article.
Association between increased peripheral blood CD86-positive plasmacytoid dendritic cells and immune-related adverse events in patients with non-small cell lung cancer.
Karayama M, Mizoguchi Y, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T, Kitano S, Aoki K, Yamada Y. Karayama M, et al. Among authors: suzuki y. Glob Health Med. 2022 Dec 31;4(6):301-308. doi: 10.35772/ghm.2022.01052. Glob Health Med. 2022. PMID: 36589213 Free PMC article.
Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy.
Inoue Y, Inui N, Karayama M, Asada K, Fujii M, Matsuura S, Uto T, Hashimoto D, Matsui T, Ikeda M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Suda T. Inoue Y, et al. Among authors: suzuki y. Cancer Immunol Immunother. 2023 Aug;72(8):2717-2728. doi: 10.1007/s00262-023-03453-z. Epub 2023 Apr 26. Cancer Immunol Immunother. 2023. PMID: 37099186 Free PMC article.
Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapy.
Kitahara Y, Inoue Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Funai K, Honda T, Misawa K, Miyake H, Takeuchi H, Inui N, Suda T. Kitahara Y, et al. Among authors: suzuki y. Respir Res. 2024 Jan 10;25(1):25. doi: 10.1186/s12931-024-02683-8. Respir Res. 2024. PMID: 38200501 Free PMC article.
CLEC10A expression defines functionally distinct subsets of conventional type 2 dendritic cells (cDC2) in the mouse lung.
Nihashi F, Furuhashi K, Horiguchi R, Kitahara Y, Inoue Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. Nihashi F, et al. Among authors: suzuki y. Allergol Int. 2024 Feb 9:S1323-8930(24)00012-1. doi: 10.1016/j.alit.2024.01.011. Online ahead of print. Allergol Int. 2024. PMID: 38341372 Free article. No abstract available.
Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study.
Miyashita K, Hozumi H, Furuhashi K, Nakatani E, Inoue Y, Yasui H, Suzuki Y, Karayama M, Enomoto N, Fujisawa T, Inui N, Ojima T, Suda T. Miyashita K, et al. Among authors: suzuki y. Respir Res. 2024 Feb 21;25(1):95. doi: 10.1186/s12931-024-02723-3. Respir Res. 2024. PMID: 38383463 Free PMC article.
Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study.
Enomoto N, Yazawa S, Mochizuka Y, Fukada A, Tanaka Y, Naoi H, Aono Y, Inoue Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Furuhashi K, Toyoshima M, Kono M, Imokawa S, Sano T, Akamatsu T, Koshimizu N, Yokomura K, Matsuda H, Kaida Y, Shirai M, Mori K, Masuda M, Fujisawa T, Inui N, Nakamura Y, Sugiura H, Sumikawa H, Kitani M, Tabata K, Ogawa N, Suda T. Enomoto N, et al. Among authors: suzuki y. Respir Med. 2024 Apr;224:107577. doi: 10.1016/j.rmed.2024.107577. Epub 2024 Feb 24. Respir Med. 2024. PMID: 38408707 Free article.
Treatments of refractory eosinophilic lung diseases with biologics.
Asano K, Suzuki Y, Tanaka J, Kobayashi K, Kamide Y. Asano K, et al. Among authors: suzuki y. Allergol Int. 2023 Jan;72(1):31-40. doi: 10.1016/j.alit.2022.10.004. Epub 2022 Nov 1. Allergol Int. 2023. PMID: 36333218 Free article. Review.
16,401 results
You have reached the last available page of results. Please see the User Guide for more information.